Tag: ICH Q1A(R2) accelerated testing

Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation

Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation Introduction In the pharmaceutical industry, time-to-market and regulatory readiness are key considerations in drug development. Accelerated stability testing serves as a pivotal technique that allows scientists to predict the long-term stability of active…

Accelerated Stability Testing of APIs, Stability Studies for APIs

Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation

Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation Accelerated Stability Testing of APIs: Strategies for Rapid Shelf Life Estimation Introduction Accelerated stability testing is a critical component of pharmaceutical development, offering a scientific pathway to predict the long-term behavior of Active Pharmaceutical Ingredients (APIs) under controlled stress conditions. It allows manufacturers to…

Accelerated Stability Testing of APIs, Stability Studies for APIs

Sample Size Determination in Accelerated Stability Studies

Sample Size Determination in Accelerated Stability Studies How to Determine Sample Size for Accelerated Stability Studies in Pharmaceuticals Accelerated stability studies provide critical early insights into the shelf life and degradation profile of pharmaceutical products. A key component of designing such studies is determining the appropriate number of samples to be tested at each interval….

Real-Time and Accelerated Stability Studies, Stability Testing Types